Related MeSH Hierarchy (5)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Adrenocortical Carcinoma
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms » Adrenal Gland Neoplasms » Adrenal Cortex Neoplasms » Adrenocortical Carcinoma
Diseases [C] » Endocrine System Diseases [C19] » Adrenal Gland Diseases » Adrenal Cortex Diseases » Adrenal Cortex Neoplasms » Adrenocortical Carcinoma
Diseases [C] » Endocrine System Diseases [C19] » Adrenal Gland Diseases » Adrenal Gland Neoplasms » Adrenal Cortex Neoplasms » Adrenocortical Carcinoma
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms » Adrenal Gland Neoplasms » Adrenal Cortex Neoplasms » Adrenocortical Carcinoma
Description
A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM. MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (6)
Phase 2 Indicated Drugs (30)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (27)
Organization Involved with Phase 1 Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
